Close Menu
Home » siRNA

siRNA

Oct 23, 2019

Biotech Startup Korro Bio Uses Temporary Gene Editing Technology to Create Therapeutics

Premium

The company's platform is based on nucleotide deamination, a process that occurs naturally in cells and doesn't create a permanent edit in the genome.

Jan 29, 2019

This Week in PNAS: Jan 29, 2019

In PNAS this week: Fanconi anemia protein role in ribosome biogenesis, small interfering RNAs in A. thaliana seeds development, and more.

Aug 31, 2017

Cowen Initiates Coverage of Horizon Discovery at Outperform

The investment bank began coverage with an Outperform rating, noting that Horizon's recent acquisition of Dharmacon is highly complementary and synergistic.

Jul 08, 2015

Startup Persomics Aims to Launch Mini RNAi Screening Tech by Year-End

Premium

With optimization work currently being done with beta testers, the company is negotiating with companies to provide their siRNA library content on its plates.

Aug 14, 2014

IP Update: Recent Patents Awarded to Alnylam, Tekmira, Polyplus, and More

Premium

Title: RNA Interference Modulators of Hedgehog Signaling and Uses Thereof
Patent Number: 8,802,639
Filed: March 24, 2005

Jun 26, 2014

InteRNA, Collaborators Publish Details of siRNA, microRNA Delivery Technology

Premium

NEW YORK (GenomeWeb) – InteRNA Technologies and academic collaborators this month reported details of an siRNA-delivery technology capable of specifically targeting tumor vasculature, along with in vitro data demonstrating its ability to carry siRNAs into human umbilical vein endothelial

Jan 09, 2014

Dicerna Poised to Become Second RNAi Drug Firm to Complete IPO

Premium

Should Dicerna Pharmaceuticals complete its planned initial public offering, the company would be the first RNAi drug developer to go public since Alnylam Pharmaceuticals did so in 2004.

Jan 07, 2014

Horizon, AstraZeneca Collaborate on Genotypes for Synthetic Lethality

NEW YORK (GenomeWeb News) – Horizon Discovery today announced a research collaboration and licensing deal with AstraZeneca to interrogate oncology-relevant genotypes in order to identify and validate new drug targets.

Dec 12, 2013

Life Tech Allows Release of Full siRNA Sequence Data from NIH RNAi Screens

Premium

This article has been updated to include information about Life Technologies' spokesperson.

Nov 25, 2013

RNAi Screen Finds Regulators of Parkin, Suggests Possible Therapeutic Targets

NEW YORK (GenomeWeb News) – Using genome-wide RNAi screens, Richard Youle at the US National Institute of Neurological Disorders and Stroke and his colleagues have identified a bevy of regulators of

Pages

The Scan

Hundreds and Hundreds Retracted

The Washington Post reports that a Russian Academy of Sciences commission has led to the retraction of hundreds of scientific papers.

Guilty Plea in Kickback Case

The Los Angeles Times' Daily Pilot reports the chief executive of Vantari Genetics has pleaded guilty in a kickback scheme.

Florida Bill Moves Ahead

News 4 Jax reports that a Florida bill to prevent life and long-term care insurers from using genetic information in their coverage decisions has easily passed one committee.

Science Presents Studies Into Disease-Causing Mutations Among Bone Marrow Donors; Links Between Heavy Drinking, Other Disease

In Science this week: potentially pathogenic mutations found in hematopoietic stem cells from young healthy donors, and more.

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.